{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:15:00Z","timestamp":1792984500022,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T00:00:00Z","timestamp":1433548800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12964-015-0104-z","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T07:41:47Z","timestamp":1433490107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B"],"prefix":"10.1186","volume":"13","author":[{"given":"Oddrun Elise","family":"Olsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin Fahl","family":"Wader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Hella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K\u00e6rsgaard","family":"Mylin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingemar","family":"Turesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingerid","family":"Nesthus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Waage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Sundan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toril","family":"Holien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,6]]},"reference":[{"key":"104_CR1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1097-2765(03)00386-1","volume":"12","author":"MJ Goumans","year":"2003","unstructured":"Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta\/ALK5 signaling. Mol Cell. 2003;12:817\u201328.","journal-title":"Mol Cell"},{"key":"104_CR2","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1096\/fj.07-8080com","volume":"21","author":"M Eijken","year":"2007","unstructured":"Eijken M, Swagemakers S, Koedam M, Steenbergen C, Derkx P, Uitterlinden AG, et al. The activin A-follistatin system: potent regulator of human extracellular matrix mineralization. FASEB J. 2007;21:2949\u201360.","journal-title":"FASEB J"},{"key":"104_CR3","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/leu.2013.385","volume":"28","author":"R Silbermann","year":"2014","unstructured":"Silbermann R, Bolzoni M, Storti P, Guasco D, Bonomini S, Zhou D, et al. Bone marrow monocyte-\/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma. Leukemia. 2014;28:951\u20134.","journal-title":"Leukemia"},{"key":"104_CR4","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1182\/blood-2011-03-342691","volume":"117","author":"S Sozzani","year":"2011","unstructured":"Sozzani S, Musso T. The yin and yang of Activin A. Blood. 2011;117:5013\u20135.","journal-title":"Blood"},{"key":"104_CR5","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1073\/pnas.0911929107","volume":"107","author":"S Vallet","year":"2010","unstructured":"Vallet S, Mukherjee S, Vaghela N, Hideshima T, Fulciniti M, Pozzi S, et al. Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease. Proc Natl Acad Sci U S A. 2010;107:5124\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"104_CR6","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/annonc\/mds068","volume":"23","author":"E Terpos","year":"2012","unstructured":"Terpos E, Kastritis E, Christoulas D, Gkotzamanidou M, Eleutherakis-Papaiakovou E, Kanellias N, et al. Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy. Ann Oncol. 2012;23:2681\u20136.","journal-title":"Ann Oncol"},{"key":"104_CR7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2011.06.030","volume":"359","author":"KL Walton","year":"2012","unstructured":"Walton KL, Makanji Y, Harrison CA. New insights into the mechanisms of activin action and inhibition. Mol Cell Endocrinol. 2012;359:2\u201312.","journal-title":"Mol Cell Endocrinol"},{"key":"104_CR8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0092-8674(93)90488-C","volume":"75","author":"L Attisano","year":"1993","unstructured":"Attisano L, Carcamo J, Ventura F, Weis FM, Massague J, Wrana JL. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell. 1993;75:671\u201380.","journal-title":"Cell"},{"key":"104_CR9","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.cellsig.2013.09.002","volume":"25","author":"CA Rejon","year":"2013","unstructured":"Rejon CA, Hancock MA, Li YN, Thompson TB, Hebert TE, Bernard DJ. Activins bind and signal via bone morphogenetic protein receptor type II (BMPR2) in immortalized gonadotrope-like cells. Cell Signal. 2013;25:2717\u201326.","journal-title":"Cell Signal"},{"key":"104_CR10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0092-8674(94)90320-4","volume":"77","author":"A Hemmati-Brivanlou","year":"1994","unstructured":"Hemmati-Brivanlou A, Kelly OG, Melton DA. Follistatin, an antagonist of activin, is expressed in the Spemann organizer and displays direct neuralizing activity. Cell. 1994;77:283\u201395.","journal-title":"Cell"},{"key":"104_CR11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00281-013-0365-9","volume":"35","author":"P Sideras","year":"2013","unstructured":"Sideras P, Apostolou E, Stavropoulos A, Sountoulidis A, Gavriil A, Apostolidou A, et al. Activin, neutrophils, and inflammation: just coincidence? Semin Immunopathol. 2013;35:481\u201399.","journal-title":"Semin Immunopathol"},{"key":"104_CR12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/leu.2011.263","volume":"26","author":"T Holien","year":"2012","unstructured":"Holien T, Vatsveen TK, Hella H, Rampa C, Brede G, Groseth LA, et al. Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC. Leukemia. 2012;26:1073\u201380.","journal-title":"Leukemia"},{"key":"104_CR13","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2014.16","volume":"4","author":"OE Olsen","year":"2014","unstructured":"Olsen OE, Wader KF, Misund K, Vatsveen TK, Ro TB, Mylin AK, et al. Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin. Blood Cancer J. 2014;4, e196.","journal-title":"Blood Cancer J"},{"key":"104_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/mol.62.1.65","volume":"62","author":"GJ Inman","year":"2002","unstructured":"Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2002;62:65\u201374.","journal-title":"Mol Pharmacol"},{"key":"104_CR15","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1038\/sj.onc.1207386","volume":"23","author":"TB Ro","year":"2004","unstructured":"Ro TB, Holt RU, Brenne AT, Hjorth-Hansen H, Waage A, Hjertner O, et al. Bone morphogenetic protein-5, \u22126 and \u22127 inhibit growth and induce apoptosis in human myeloma cells. Oncogene. 2004;23:3024\u201332.","journal-title":"Oncogene"},{"key":"104_CR16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cytogfr.2014.04.009","volume":"25","author":"T Holien","year":"2014","unstructured":"Holien T, Sundan A. The role of bone morphogenetic proteins in myeloma cell survival. Cytokine Growth Factor Rev. 2014;25:343\u201350.","journal-title":"Cytokine Growth Factor Rev"},{"key":"104_CR17","doi-asserted-by":"crossref","first-page":"20948","DOI":"10.1074\/jbc.M800850200","volume":"283","author":"K Lavery","year":"2008","unstructured":"Lavery K, Swain P, Falb D, Alaoui-Ismaili MH. BMP-2\/4 and BMP-6\/7 Differentially Utilize Cell Surface Receptors to Induce Osteoblastic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells. J Biol Chem. 2008;283:20948\u201358.","journal-title":"J Biol Chem"},{"key":"104_CR18","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjh.12835","volume":"165","author":"KM Abdulkadyrov","year":"2014","unstructured":"Abdulkadyrov KM, Salogub GN, Khuazheva NK, Sherman ML, Laadem A, Barger R, et al. Sotatercept in patients with osteolytic lesions of multiple myeloma. Br J Haematol. 2014;165:814\u201323.","journal-title":"Br J Haematol"},{"key":"104_CR19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.3512","volume":"20","author":"RN Suragani","year":"2014","unstructured":"Suragani RN, Cadena SM, Cawley SM, Sako D, Mitchell D, Li R, et al. Transforming growth factor-beta superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nat Med. 2014;20:408\u201314.","journal-title":"Nat Med"},{"key":"104_CR20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1182\/blood.V97.2.516","volume":"97","author":"O Hjertner","year":"2001","unstructured":"Hjertner O, Hjorth-Hansen H, Borset M, Seidel C, Waage A, Sundan A. Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood. 2001;97:516\u201322.","journal-title":"Blood"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-015-0104-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12964-015-0104-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-015-0104-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:40:47Z","timestamp":1553640047000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biosignaling.com\/content\/13\/1\/27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,6]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["104"],"URL":"https:\/\/doi.org\/10.1186\/s12964-015-0104-z","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,6]]},"article-number":"27"}}